From China With IO: Lilly Bets $1bn+ To Take Innovent Drug Global

Chinese Firm To Internationalize Via Wider Partnership

 
• By Brian Yang
China - Suzhou City
LILLY OBTAINS GLOBAL RIGHTS TO IO DRUG FROM SUZHOU-BASED INNOVENT BIO • Source: Shutterstock

More from Immuno-oncology

More from Anticancer